u Pre-formulation research
u Formulation process research
u Pilot-scale amplification research
u Commercial batch/registration batch production
u Quality research services for raw and excipient drugs
u Stability investigation services
Service scope of conventional drug clinical pharmacological research
u Small molecule Phase I clinical research
u Macromolecule Phase I clinical research
u Human bioequivalence test research
u Bioequivalence test research of complex preparations
Service scope of conventional drug multicenter clinical research
u Innovative drug Phase II and III clinical research
u Confirmatory clinical research
u Special medical food clinical research
u Medical device clinical research
Service scope of innovative technology multicenter clinical research
u Investigator-initiated clinical research (IIT) of cell or gene preparations
u Cell or gene preparations Phase I, II and III clinical research
Service scope of multicenter clinical research of ophthalmic products
u Investigator-initiated clinical research (IIT) of ophthalmic drugs
u Ophthalmic drug Phase I, II and III clinical research
u Ophthalmic medical device clinical research
u Real-world research
u Phase IV clinical research
u Post-marketing drug re-evaluation initiated by investigators or sponsors
u Evaluation of evidence-based medicine and pharmacoeconomics
u Safety re-evaluation of traditional Chinese medicine injections
u Development and validation of biological analysis methods for drugs and their metabolites
u Pharmacokinetic sample analysis of drugs and their metabolites
u Development and validation of drug biological analysis methods
u Pharmacokinetic sample analysis of drugs
u Immunogenicity sample analysis of drugs
u Neutralizing antibody sample analysis of drugs
u Biomarker sample analysis of drugs
u Compliance review of research materials
u Consultation on clinical research and development strategies
u Government affairs
u Formulation of registration strategies
